These results demonstrated that metformin inhibits LCA-induced IL-8 expression in HCT116 CRC cells, in turn obstructing LCA’s stimulatory effect on endothelial cell proliferation and tubelike formation in tumor environments. This evidence concerns the gene CXCL8 and colorectal carcinoma.